Skip to main content
Top
Published in: Journal of Cancer Education 2/2020

01-04-2020 | Care

Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice

Authors: Alexandra Hua, Mary E. Sesto, Xiao Zhang, Timothy R. Wassenaar, Amye J. Tevaarwerk

Published in: Journal of Cancer Education | Issue 2/2020

Login to get access

Abstract

With a growing number of cancer survivors, survivorship care plans (SCPs) are recommended to communicate information about late effects of treatment and follow-up care. Community oncology practices follow 85% of adult cancer survivors but report more difficulty in providing SCPs compared to academic centers. Our objective was to evaluate the impact of delivering SCPs in a community oncology practice by examining awareness of SCP receipt as well as how provision affects survivors’ perception of care quality and of their condition. Survivors who accepted a SCP as standard of care were recruited from a community oncology practice in the Midwest and completed surveys prior to SCP provision (baseline) and 4 weeks later (follow-up). Within-survivor changes in knowledge of SCP receipt, satisfaction and perceived care coordination were assessed. Thirty cancer survivors (breast, colon, and prostate) completed the baseline survey, while 24 completed the follow-up survey (80% response rate). Participants reported receiving SCPs and treatment summaries more frequently at follow-up after receiving a SCP. At follow-up, there was a significant increase in survivor activation and involvement in care along with satisfaction of knowledge of care. Communication about and during SCP provision may need to be clearer: 34% of survivors could not correctly identify SCP receipt in this study. This may place these survivors at a disadvantage, if this leads to less awareness of important information regarding follow-up surveillance and management. Of those aware of SCP receipt, SCP provision had positive impacts in this small, short-term study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Institute, National Cancer (2017) Cancer statistics. Accessed 2018 Institute, National Cancer (2017) Cancer statistics. Accessed 2018
2.
go back to reference Medicine, Institute of, and National Research Council (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC Medicine, Institute of, and National Research Council (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC
8.
go back to reference Society, American Cancer. 2018. Survivorship care plans. Accessed 2018. Society, American Cancer. 2018. Survivorship care plans. Accessed 2018.
9.
go back to reference Birken SA, Mayer DK, Weiner BJ (2013) Survivorship care plans: prevalence and barriers to use. J Cancer Educ 28(2):290–296CrossRef Birken SA, Mayer DK, Weiner BJ (2013) Survivorship care plans: prevalence and barriers to use. J Cancer Educ 28(2):290–296CrossRef
11.
go back to reference de Rooij BH, Ezendam NPM, Nicolaije KAH, Caroline Vos M, Pijnenborg JMA, Boll D, Boss EA, Hermans RHM, Engelhart KCM, Haartsen JE, Pijlman BM, van Loon-Baelemans IEAM, Mertens HJMM, Nolting WE, van Beek JJ, Roukema JA, Kruitwagen RFPM, van de Poll-Franse LV (2017) Effects of survivorship care plans on patient reported outcomes in ovarian cancer during 2-year follow-up - the ROGY care trial. Gynecol Oncol 145(2):319–328. https://doi.org/10.1016/j.ygyno.2017.02.041. CrossRefPubMed de Rooij BH, Ezendam NPM, Nicolaije KAH, Caroline Vos M, Pijnenborg JMA, Boll D, Boss EA, Hermans RHM, Engelhart KCM, Haartsen JE, Pijlman BM, van Loon-Baelemans IEAM, Mertens HJMM, Nolting WE, van Beek JJ, Roukema JA, Kruitwagen RFPM, van de Poll-Franse LV (2017) Effects of survivorship care plans on patient reported outcomes in ovarian cancer during 2-year follow-up - the ROGY care trial. Gynecol Oncol 145(2):319–328. https://​doi.​org/​10.​1016/​j.​ygyno.​2017.​02.​041.​ CrossRefPubMed
12.
go back to reference Tevaarwerk AJ, Wisinski KB, Buhr KA, Njiaju UO, Tun M, Donohue S, Sekhon N, Yen T, Wiegmann DA, Sesto ME (2014) Leveraging electronic health record systems to create and provide electronic cancer survivorship care plans: a pilot study. J Oncol Pract 10(3):e150–e159CrossRef Tevaarwerk AJ, Wisinski KB, Buhr KA, Njiaju UO, Tun M, Donohue S, Sekhon N, Yen T, Wiegmann DA, Sesto ME (2014) Leveraging electronic health record systems to create and provide electronic cancer survivorship care plans: a pilot study. J Oncol Pract 10(3):e150–e159CrossRef
16.
go back to reference Parry C, Beckjord E, Moser RP, Vieux SN, Padgett LS, Hesse BW (2015) It takes a (virtual) village: crowdsourcing measurement consensus to advance survivorship care planning. Transl Behav Med 5(1):53–59CrossRef Parry C, Beckjord E, Moser RP, Vieux SN, Padgett LS, Hesse BW (2015) It takes a (virtual) village: crowdsourcing measurement consensus to advance survivorship care planning. Transl Behav Med 5(1):53–59CrossRef
17.
go back to reference Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM (2005) Development and validation of the patient assessment of chronic illness care (PACIC). Med Care 43(5):436–444CrossRef Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM (2005) Development and validation of the patient assessment of chronic illness care (PACIC). Med Care 43(5):436–444CrossRef
19.
go back to reference Cleary PD, Edgman-Levitan S (1997) Health care quality. Incorporating consumer perspectives. JAMA 278(19):1608–1612CrossRef Cleary PD, Edgman-Levitan S (1997) Health care quality. Incorporating consumer perspectives. JAMA 278(19):1608–1612CrossRef
23.
Metadata
Title
Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice
Authors
Alexandra Hua
Mary E. Sesto
Xiao Zhang
Timothy R. Wassenaar
Amye J. Tevaarwerk
Publication date
01-04-2020
Publisher
Springer US
Keyword
Care
Published in
Journal of Cancer Education / Issue 2/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-018-1457-y

Other articles of this Issue 2/2020

Journal of Cancer Education 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine